Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles

Molecular evidence and clinical importance of β-arrestins expression in patients with acromegaly

(2018) Maria Caroline Alves Coelho et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment

(2017) E. Peverelli et al.   INTERNATIONAL JOURNAL OF CANCER

In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas

(2017) Federico Gatto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Somatostatin receptor ligands in the treatment of acromegaly

(2017) Monica R. Gadelha et al.   Pituitary

FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression

(2017) Eleonora Vitali et al.   Oncotarget

RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D 2 and D 3 receptor

(2016) Mei Zheng et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker

(2016) Daniel Hormaechea-Agulla et al.   CANCER LETTERS

Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours

(2016) Eleonora Vitali et al.   ENDOCRINE-RELATED CANCER

Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors

(2016) Alessandra Mingione et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

(2015) Donato Iacovazzo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification

(2015) Alexander S. G. Micko et al.   JOURNAL OF NEUROSURGERY

Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly

(2015) Annamaria Colao et al.   Pituitary

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement

(2015) Erika Peverelli et al.   Frontiers in Endocrinology

Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells

(2014) E. Peverelli et al.   ENDOCRINOLOGY

Acromegaly: An Endocrine Society Clinical Practice Guideline

(2014) Laurence Katznelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression

(2013) Leandro Kasuki et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern

(2013) Leandro Kasuki et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Inhibition of Filamin-A Reduces Cancer Metastatic Potential

(2013) Xi Jiang et al.   International Journal of Biological Sciences

Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide

(2013) Olivera Casar-Borota et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Filamin A controls matrix metalloproteinase activity and regulates cell invasion in human fibrosarcoma cells

(2012) M. Baldassarre et al.   JOURNAL OF CELL SCIENCE

Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly

(2012) Federico Gatto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel pathway for somatostatin analogs in patients with acromegaly

(2012) Mônica R. Gadelha et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Place of Cabergoline in Acromegaly: A Meta-Analysis

(2011) Laure Sandret et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents

(2010) Jose Córdoba-Chacón et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Filamin A mediates interactions between cytoskeletal proteins that control cell adhesion

(2010) Hugh Kim et al.   FEBS LETTERS

Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion

(2010) Yingjie Xu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

R-Ras Regulates Migration through an Interaction with Filamin A in Melanoma Cells

(2010) Joanna E. Gawecka et al.   PLoS One

Filamins in cell signaling, transcription and organ development

(2010) Alex-Xianghua Zhou et al.   TRENDS IN CELL BIOLOGY

Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases

(2009) R. G. Bedolla et al.   CLINICAL CANCER RESEARCH

Characterization of Intracellular Signaling Mediated by Human Somatostatin Receptor 5: Role of the DRY Motif and the Third Intracellular Loop

(2009) Erika Peverelli et al.   ENDOCRINOLOGY

Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

(2008) Giselle F Taboada et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY